Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
& Kordower, J
Trial in progress: Phase 1 study of BI 1823911, an irreversible KRASG12C inhibitor targeting KRAS in its GDP-loaded state, as monotherapy and in combination with the pan-KRAS SOS1 inhibitor BI 1701963 in solid tumors expressing KRASG12C mutation
In addition to its role in energy production, L-Carnitine might have other potential wellness benefits
Glutathione l mt cht chng oxy ha mnh m c kh nng trung ha cc gc t do, gip bo v t bo v ngn chn s hnh thnh melanin nguyn nhn gy ra nm, tn nhang v sm da
What To Do If Adverse Reaction Occurs For mild symptoms (headache, nausea): Monitor and adjust dose
US$ 23.98
US$ 25.79
US$ 27.83
:max_bytes(150000):strip_icc()/VWH-GettyImages-1786881870-92c02c69953b4fa6a2946b46bf5d5e31.jpg)
US$ 22.86
